<code id='FC8C18A472'></code><style id='FC8C18A472'></style>
    • <acronym id='FC8C18A472'></acronym>
      <center id='FC8C18A472'><center id='FC8C18A472'><tfoot id='FC8C18A472'></tfoot></center><abbr id='FC8C18A472'><dir id='FC8C18A472'><tfoot id='FC8C18A472'></tfoot><noframes id='FC8C18A472'>

    • <optgroup id='FC8C18A472'><strike id='FC8C18A472'><sup id='FC8C18A472'></sup></strike><code id='FC8C18A472'></code></optgroup>
        1. <b id='FC8C18A472'><label id='FC8C18A472'><select id='FC8C18A472'><dt id='FC8C18A472'><span id='FC8C18A472'></span></dt></select></label></b><u id='FC8C18A472'></u>
          <i id='FC8C18A472'><strike id='FC8C18A472'><tt id='FC8C18A472'><pre id='FC8C18A472'></pre></tt></strike></i>

          fashion

          fashion

          author:focus    Page View:9
          Mayo Clinic, in Rochester, Minnesota on
          Photo by KEREM YUCEL/AFP via Getty Images

          SAN FRANCISCO — Mayo Clinic has signed Silicon Valley tech startup Cerebras as its first generative AI partner, the health system announced Monday.

          The health system — known for its cutting-edge research and willingness to partner with tech companies — will give Cerebras millions of dollars to help build technology tools based on Mayo’s trove of de-identified patient data, leaders announced at the J.P. Morgan Healthcare Conference. Mayo and Cerebras did not disclose the dollar amount, but Cerebras said it was a multimillion, multi-year contract.

          advertisement

          With roughly 380 employees, Cerebras builds and sells supercomputers specifically designed for AI applications across several industries — pitting the upstart in direct competition with the market leader Nvidia Corp. Life sciences giants including GSK have used its technology for drug discovery, and it has partnered with a health network in United Arab Emirates, but this is Cerebras’ first AI contract with a U.S. health system. The deal gives Mayo access to Cerebras’ supercomputers as well as a Cerebras team to help develop health-tuned models; Mayo will then own whatever they build.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          After affirmative action ruling, medical educators look to 'holistic review'
          After affirmative action ruling, medical educators look to 'holistic review'

          AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

          read more
          Will the IRA bring competition to the biologics market?
          Will the IRA bring competition to the biologics market?

          AdobeOnAug.29,Medicarereleaseditshighlyanticipatedlistof10therapiesforwhichitplanstoestablishapriceb

          read more
          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more

          How many hemophilia patients actually want gene therapy?

          AdobeAsaboygrowingupwithhemophiliaA,NoahFrederickreservedtheendofhisannualcheckupstotalkaboutnewtech